Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)
China
· Delayed Price · Currency is CNY 9.87
-0.12 (-1.20%)
Mar 11, 2026, 3:04 PM CST
SHE:300534 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 27.83 | 25.8 | 61.65 | 38.79 | -9.11 | 1.83 | Upgrade
|
| Depreciation & Amortization | 37.48 | 37.48 | 29.9 | 26.99 | 22.56 | 19.5 | Upgrade
|
| Other Amortization | 0.62 | 0.62 | 0.06 | 0.02 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.69 | 0.69 | 0.24 | - | -0.07 | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0.1 | 4.79 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.39 | -0.39 | - | -0.91 | -0.8 | -0.6 | Upgrade
|
| Provision & Write-off of Bad Debts | -1.36 | -1.36 | 8.9 | 5.28 | 1.14 | 3 | Upgrade
|
| Other Operating Activities | -263.46 | 29.68 | 26.23 | 10.66 | 3.73 | -0.04 | Upgrade
|
| Change in Accounts Receivable | 5.82 | 5.82 | 2.59 | -68.12 | 34.53 | -3.18 | Upgrade
|
| Change in Inventory | -18.52 | -18.52 | -11.65 | 19.62 | -12.79 | -2.04 | Upgrade
|
| Change in Accounts Payable | 90.01 | 90.01 | -20.1 | 235.47 | 8.28 | 26.35 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | -0.65 | -1.12 | -1.33 | Upgrade
|
| Operating Cash Flow | -120.97 | 170.14 | 96.53 | 267.44 | 51.13 | 43.5 | Upgrade
|
| Operating Cash Flow Growth | - | 76.27% | -63.91% | 423.01% | 17.55% | 54.21% | Upgrade
|
| Capital Expenditures | -63.04 | -78.22 | -126.36 | -25.41 | -0.41 | -18.55 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | - | - | - | 0.01 | 0 | Upgrade
|
| Investment in Securities | - | - | - | 15 | - | - | Upgrade
|
| Other Investing Activities | 0.8 | 0.6 | - | -14.09 | 0.8 | 0.6 | Upgrade
|
| Investing Cash Flow | -62.24 | -77.62 | -126.36 | -24.5 | 0.4 | -17.95 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 70 | Upgrade
|
| Long-Term Debt Issued | - | 9.92 | 142 | - | - | - | Upgrade
|
| Total Debt Issued | 34.56 | 9.92 | 142 | - | - | 70 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -24 | Upgrade
|
| Long-Term Debt Repaid | - | -45.09 | -3.11 | -20 | -70.07 | - | Upgrade
|
| Total Debt Repaid | 35.03 | -45.09 | -3.11 | -20 | -70.07 | -24 | Upgrade
|
| Net Debt Issued (Repaid) | 69.6 | -35.17 | 138.89 | -20 | -70.07 | 46 | Upgrade
|
| Issuance of Common Stock | 2 | 1 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -14.65 | -15.29 | -3.82 | -0.49 | - | -4.99 | Upgrade
|
| Other Financing Activities | -30.13 | -42.1 | -185.79 | 1.32 | -0.53 | - | Upgrade
|
| Financing Cash Flow | 26.81 | -91.57 | -50.72 | -19.17 | -70.6 | 41.01 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | - | -0.01 | Upgrade
|
| Net Cash Flow | -156.4 | 0.96 | -80.55 | 223.77 | -19.07 | 66.55 | Upgrade
|
| Free Cash Flow | -184.01 | 91.93 | -29.83 | 242.03 | 50.72 | 24.95 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 377.18% | 103.30% | - | Upgrade
|
| Free Cash Flow Margin | -20.12% | 8.85% | -2.76% | 30.27% | 17.62% | 9.79% | Upgrade
|
| Free Cash Flow Per Share | -0.61 | 0.30 | -0.10 | 0.80 | 0.17 | 0.08 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 0.53 | - | Upgrade
|
| Cash Income Tax Paid | 149.88 | 155.58 | 135.24 | 58.17 | 20.13 | 16 | Upgrade
|
| Levered Free Cash Flow | -177.23 | 91.32 | -47.68 | 226.77 | 56.23 | 4.02 | Upgrade
|
| Unlevered Free Cash Flow | -175.65 | 93.27 | -45.22 | 227.07 | 56.56 | 5.31 | Upgrade
|
| Change in Working Capital | 77.62 | 77.62 | -30.45 | 186.52 | 28.89 | 19.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.